Lord, Abbett & Co
NXTC icon

Lord, Abbett & Co’s NextCure NXTC Stock Holding History

Lord, Abbett & Co’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-147,012
Closed -$37.8M – 667
2020
Q2 		$37.8M Sell
147,012
-31,100
-17% -$11.8M 0.13% 251
2020
Q1 		$79.2M Buy
178,112
+57,920
+48% +$30.9M 0.35% 78
2019
Q4 		$81.2M Buy
120,192
+78,803
+190% +$39.5M 0.27% 108
2019
Q3 		$15.3M Buy
+41,389
New +$13.5M 0.05% 457

Other funds holding NXTC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Lord, Abbett & Co's NXTC Position: Q3 2020 in Review

Lord, Abbett & Co sold out of NextCure (NXTC) in Q3 2020, closing a stake of 147,012 shares — an estimated $37.8M sold.

Lord, Abbett & Co first reported a position in NXTC in Q3 2019 and held it in 4 quarters. The position peaked at $81.2M in Q4 2019. 75 funds tracked by Wall St. Rank hold NXTC as of Q3 2020.

  • Lord, Abbett & Co reported no remaining NextCure position as of Q3 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 147,012 NextCure shares in Q3 2020, an estimated $37.8M.
  • Lord, Abbett & Co first reported a position in NextCure in Q3 2019 and held it in 4 quarters.
  • Lord, Abbett & Co's NextCure position peaked at $81.2M in Q4 2019.
  • 75 funds tracked by Wall St. Rank held NextCure as of Q3 2020.

Based on Lord, Abbett & Co's 13F filing for Q3 2020, filed 12 Nov 2020.